Czech Republic - Domestic private health expenditure per capita, PPP (current international $)

The latest value for Domestic private health expenditure per capita, PPP (current international $) in Czech Republic was 643.30 as of 2019. Over the past 19 years, the value for this indicator has fluctuated between 643.30 in 2019 and 104.37 in 2000.

Definition: Current private expenditures on health per capita expressed in international dollars at purchasing power parity (PPP).

Source: World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).

See also:

Year Value
2000 104.37
2001 129.54
2002 134.41
2003 159.43
2004 164.70
2005 207.24
2006 213.81
2007 255.78
2008 337.89
2009 345.30
2010 324.06
2011 327.90
2012 336.12
2013 394.86
2014 430.90
2015 433.75
2016 465.43
2017 507.92
2018 553.29
2019 643.30

Development Relevance: Strengthening health financing is one objective of Sustainable Development Goal 3 (SDG target 3.c). The levels and trends of health expenditure data identify key issues such as weaknesses and strengths and areas that need investment, for instance additional health facilities, better health information systems, or better trained human resources. Health financing is also critical for reaching universal health coverage (UHC) defined as all people obtaining the quality health services they need without suffering financial hardship (SDG 3.8). The data on out-of-pocket spending is a key indicator with regard to financial protection and hence of progress towards UHC.

Original Source Notes: The World Health Organization (WHO) has revised health expenditure data using the new international classification for health expenditures in the revised System of Health Accounts (SHA 2011). WHO’s Global Health Expenditure Database in this new version i

Statistical Concept and Methodology: The health expenditure estimates have been prepared by the World Health Organization under the framework of the System of Health Accounts 2011 (SHA 2011). The Health SHA 2011 tracks all health spending in a given country over a defined period of time regardless of the entity or institution that financed and managed that spending. It generates consistent and comprehensive data on health spending in a country, which in turn can contribute to evidence-based policy-making.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Health systems